Back

Koninklijke DSM N.V.

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 11 feb 2015 - 07:15
  • Statutory name Koninklijke DSM N.V.
  • Title DSM reports 2014 results
  • Comments • 2014 sales of €9,181 million • Organic sales growth 5% in Q4 2014 and 3% for 2014 • Q4 2014 EBITDA €288 million and 2014 EBITDA €1,168 million • Strong cash from operating activities of €418 million in Q4 2014 (€808 million in 2014) • Non-cash impairment of €186 million of the caprolactam business (after tax and non-controlling interests) included in exceptional items, leading to a net loss in Q4 2014 • Proposed dividend stable at €1.65 per ordinary share • DSM will take further actions to improve efficiencies and to reduce costs • DSM aims to deliver 2015 EBITDA slightly ahead of 2014

Related downloads

201502110000000006_DSM_Presentation to Investors PDF.pdf
201502110000000006_DSM_Press release-PDF.pdf

Date last update: 20 October 2021

Share information

Share on: Share this